QUANTUM GENOMICS

Quantum Genomics is to develop and provide effective and well tolerated therapeutic treatments for controlling high blood pressure and to for preventing related cardio-vascular risks such as heart failure.
QUANTUM GENOMICS
Industry:
Biotechnology Health Care
Founded:
2006-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.quantum-genomics.com
Total Employee:
11+
Status:
Active
Contact:
+33 1 85 34 77 70
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Antoxis
Antoxis is developing treatments for various neurological conditions.
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2007-10-30 | Eurobiobiz | Eurobiobiz acquired by Quantum Genomics | N/A |
Key Employee Changes
Date | New article |
---|---|
2020-01-28 | Quantum Genomics Appoints Benoรฎt Gueugnon as Vice President of Finance |
Official Site Inspections
http://www.quantum-genomics.com Semrush global rank: 6.65 M Semrush visits lastest month: 894
- Host name: 104.21.96.1
- IP address: 104.21.96.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Quantum Genomics"
Accueil - Quantum Genomics
La société Quantum Genomics est cotée sur le marché boursier Euronext Growth à Paris depuis le 10 avril 2014. Conseil d'administration : Mathieu Bigois, Pascal Ghoson, et Laurent de โฆSee details»
Quantum Genomics - Crunchbase Company Profile
Quantum Genomics may be growing as it has completed a strategic merger with ExactCure, which is indicated by the publication of its results for the 2023 โฆSee details»
Investisseurs - Quantum Genomics
Quantum Genomics publie ses résultats de l'exercice 2023. Le rapprochement avec ExactCure qui acte le redéploiement โฆSee details»
Quantum Genomics Société Anonyme (EPA: ALQGC) Company โฆ
Oct 24, 2024 Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs โฆSee details»
Quantum Genomics SA, 2QG:BER profile - FT.com - Financial Times
Oct 31, 2024 Quantum Genomics SA (2QG:BER) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.See details»
Company Quantum Genomics - MarketScreener.com
Sep 22, 2011 Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood โฆSee details»
Quantum Genomics (ALQGC) | Investor Relations Data & Reports
Quantum Genomics is a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, especially high โฆSee details»
Quantum Genomics Company Profile - Office Locations ... - Craft
Oct 29, 2024 Quantum Genomics has 5 employees at their 1 location and โฌ10 k in annual revenue in FY 2023. See insights on Quantum Genomics including office locations, โฆSee details»
Quantum Genomics Announces Successful Capital Raise with a โฆ
Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the patented technology platform built โฆSee details»
Accueil - Quantum Genomics
La société Quantum Genomics est cotée sur le marché boursier Euronext Growth à Paris depuis le 10 avril 2014. Conseil d'administration : Mathieu Bigois, Pascal Ghoson, et Laurent de Narbonne. Président Directeur Général : Mathieu โฆSee details»
QUANTUM GENOMICS - Quantum Genomics announces โฆ
Feb 22, 2023 Quantum Genomics announces reorganization of its Board of Directors and staff restructuration in order to focus on new projects. Quantum Genomics (Euronext Growth - โฆSee details»
Quantum Genomics - Contacts, Employees, Board Members
Quantum Genomics has 2 current employee profiles, including CEO and Managing Director Jean-Philippe Milon. Jean-Philippe Milon CEO and Managing Director Benoît Gueugnon โฆSee details»
Quantum Genomics - Investisseurs
Dec 21, 2021 A propos de Quantum Genomics. Quantum Genomics est une société biopharmaceutique spécialisée dans le développement d'une nouvelle classe de médicaments โฆSee details»
Quantum Genomics - Tech Stack, Apps, Patents & Trademarks
Nov 10, 2024 Quantum Genomics uses 13 technology products and services including HTML5, Wordpress, and Vimeo, according to G2 Stack. Quantum Genomics is actively using 16 โฆSee details»
Quantum Genomics fait le point - Boursier.com
Oct 29, 2024 Le 27 septembre 2024, Quantum Genomics a annoncé la signature d'une convention d'avance en compte courant avec Akkadian Partners Fund, un fonds โฆSee details»
Customer Stories: Genomics England - Quantum
The organization was established in 2013 by the UKโs Department of Health & Social Care to sequence the genomes of 100,000 people, generating new insights that can help improve โฆSee details»
Genomics England Case Study - Quantum
Genomics England has ambitious aims. The organization was created to sequence the genomes of an enormous number of people, generating new insights that can help improve โฆSee details»
Genomics England Scales Up Genomic Sequencing with Quantum โฆ
SAN JOSE, Calif., Sept. 10, 2020 /PRNewswire/ -- Quantum Corp. (NASDAQ: QMCO) today announced that Genomics England has expanded their Quantum ActiveScale object storage โฆSee details»
Quantum Genomics - Investisseurs
Jan 23, 2019 Quantum Genomics est une société qui a pour vocation de répondre à des besoins médicaux non satisfaits dans le domaine de la santé. Accueil ... January 22, 2019 -- The โฆSee details»
Quantum Genetix
Quantum Genetix is a leading provider of genetic testing services for Crop and Livestock management. No Search Results TAKE THE GUESSWORK OUT OF FARMING DECISIONS.See details»